dr. R.Y.J. Tamminga

E-mail:
r.y.j.tamminga umcg.nl

Research

Publications
  1. The limitation of genetic testing in diagnosing patients suspected for congenital platelet defects

    Blaauwgeers, M. W., van Asten, I., Kruip, M. J. H. A., Beckers, E. A. M., Coppens, M., Eikenboom, J., van Galen, K. P. M., Huisman, A., Korporaal, S. J. A., Ploos van Amstel, H. K., Tamminga, R. Y. J., Urbanus, R. T. & Schutgens, R. E. G., 13-Nov-2019, In : American Journal of Hematology. 3 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  2. BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

    WiN Study Grp, Atiq, F., Fijnvandraat, K., van Galen, K. P. M., Laros-Van Gorkom, B. A. P., Meijer, K., de Meris, J., Coppens, M., Mauser-Bunschoten, E. P., Cnossen, M. H., van der Bom, J. G., Eikenboom, J. & Leebeek, F. W. G., Aug-2019, In : American Journal of Hematology. 94, 8, p. E201-E205 5 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  3. Sickle cell disease: Clinical presentation and management of a global health challenge

    SCORE Consortium, Houwing, M. E., de Pagter, P. J., van Beers, E. J., Biemond, B. J., Rettenbacher, E., Rijneveld, A. W., Schols, E. M., Philipsen, J. N. J., Tamminga, R. Y. J., van Draat, K. F., Nur, E. & Cnossen, M. H., Sep-2019, In : Blood reviews. 37, 19 p., 100580.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients

    Maagdenberg, H., Bierings, M. B., van Ommen, C. H., van der Meer, F. J., Appel, I. M., Tamminga, R. Y., Cessie, S. L., Swen, J. J., der Straaten, T. V., Boer, A. D. & Maitland-van der Zee, A. H., Oct-2018, In : Pharmacogenomics. 19, 15, p. 1195-1202 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Familial macrothrombocytopenia due to a double mutation in cis in the alpha-actinin 1 gene (ACTN1), previously considered to be chronic immune thrombocytopenic purpura

    Kanhai, D., Mulder, R., Ploos van Amstel, H. K., Schutgens, R., Lukens, M. & Tamminga, R. Y. J., Dec-2018, In : Pediatric blood & cancer. 65, 12, 3 p., 27418.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (77) »

View graph of relations

ID: 150779